Neumora Therapeutics Inc (NMRA) Stock Price, Quote & News

Company Profile

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associa...

Industry: Biotechnology

Sector: Healthcare

Phone: 857 760 0900

Website: www.neumoratx.com

Address:

490 Arsenal Way, Suite 200, Watertown, United States

btown_moneymike Oct. 24 at 9:03 PM

$NMRA back to 10?

1 · Reply

_www_larval_com_ Oct. 24 at 7:52 PM

$SCNX -9%[-39%] $DVLT 4%[52%] $GNTA -4%[96%] $NMRA -3%[12%] $UMAC -3%[10%] most notable movement into the final minutes of trading.

0 · Reply

FonsieTrader Oct. 24 at 7:36 PM

$NMRA The climb still going

0 · Reply

fedeblu Oct. 24 at 7:21 PM

$NMRA what can we expect from monday call? An unexpected PR????

0 · Reply

PLATINUM_TRADES Oct. 24 at 7:04 PM

$NMRA There u go another overnight swing winner🚨🚨

0 · Reply

EC100 Oct. 24 at 6:53 PM

$NMRA holding over weekend, interesting Monday

0 · Reply

Kaltycoon Oct. 24 at 6:21 PM

$NMRA someone gambling millions of dollar on this, just saying. At this point could go either way. Black or Red for Monday spin.

1 · Reply

_www_larval_com_ Oct. 24 at 3:17 PM

$NMRA has shot 5% higher to 7% (~2Mv) in the last few minutes, 11/21 options, follow for more volatility.

0 · Reply

Mr_GA Oct. 24 at 2:42 PM

$NMRA HC Wainwright reiterates $18 price target for Neumora stock. This is the second time they have reiterated the $18 price target, as well as their initial posting of this price target. Maybe this could be a big pharma buy-out price in 2026? NMRA was trading in the $17 price range earlier this year. https://www.investing.com/news/analyst-ratings/hc-wainwright-maintains-buy-rating-on-neumora-stock-ahead-of-obesity-drug-data-93CH-4304410

0 · Reply

Kaltycoon Oct. 24 at 2:29 PM

$NMRA $NMRA nice staircase build on this, some big cahoonas scooping the dips - I’m intrigued even more.

0 · Reply

Neumora Therapeutics to Host Virtual R&D Day on October 27

Sep 2, 2025, 7:00 AM EDT - 7 weeks ago

Neumora Therapeutics to Participate in Upcoming Conferences in September

Aug 7, 2025, 2:41 AM EDT - 2 months ago

Neumora Therapeutics, Inc. (NMRA) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:05 PM EDT - 2 months ago

Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Jul 23, 2025, 7:00 AM EDT - 3 months ago

Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

Jul 9, 2025, 7:00 AM EDT - 3 months ago

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861

May 12, 2025, 7:18 PM EDT - 5 months ago

Neumora Therapeutics, Inc. (NMRA) Q1 2025 Earnings Call Transcript

May 12, 2025, 4:01 PM EDT - 5 months ago

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Apr 28, 2025, 7:00 AM EDT - 6 months ago

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

Apr 4, 2025, 4:05 PM EDT - 7 months ago

NMRA Deadline: NMRA Investors with Losses in Excess of $100K Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

Mar 30, 2025, 4:00 PM EDT - 7 months ago

NMRA Deadline: NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

Mar 27, 2025, 5:45 AM EDT - 7 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in Neumora Therapeutics, Inc. Lawsuit - NMRA

Mar 26, 2025, 2:19 AM EDT - 7 months ago

NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

Mar 15, 2025, 9:29 AM EDT - 7 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 13, 2025, 10:19 AM EDT - 8 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 6, 2025, 12:17 PM EST - 8 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in Neumora Therapeutics, Inc. Lawsuit – NMRA

Mar 4, 2025, 8:30 AM EST - 8 months ago

Neumora Therapeutics to Present at Leerink Global Healthcare Conference

Mar 3, 2025, 11:37 AM EST - 8 months ago

Neumora Therapeutics, Inc. (NMRA) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 7:00 AM EST - 8 months ago

Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 27, 2025, 5:45 AM EST - 8 months ago

Investors in Neumora Therapeutics, Inc. Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA

Feb 26, 2025, 8:46 PM EST - 8 months ago

Robbins LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors With Large Losses to Contact the Firm to Learn How They Can Recover for Their Losses

Feb 26, 2025, 1:32 PM EST - 8 months ago

Investors in Neumora Therapeutics, Inc. Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights – NMRA

Feb 20, 2025, 5:41 PM EST - 8 months ago

NMRA Investors are Suing Neumora Therapeutics, Inc.; Contact Robbins LLP for More Information

Feb 19, 2025, 10:08 PM EST - 8 months ago

NMRA REMINDER: Kessler Topaz Meltzer & Check, LLP Urges NMRA Investors with Losses to Contact the Firm

Feb 13, 2025, 7:00 AM EST - 9 months ago

Neumora Therapeutics Announces Leadership Transition

btown_moneymike Oct. 24 at 9:03 PM

$NMRA back to 10?

1 · Reply

_www_larval_com_ Oct. 24 at 7:52 PM

$SCNX -9%[-39%] $DVLT 4%[52%] $GNTA -4%[96%] $NMRA -3%[12%] $UMAC -3%[10%] most notable movement into the final minutes of trading.

0 · Reply

FonsieTrader Oct. 24 at 7:36 PM

$NMRA The climb still going

0 · Reply

fedeblu Oct. 24 at 7:21 PM

$NMRA what can we expect from monday call? An unexpected PR????

0 · Reply

PLATINUM_TRADES Oct. 24 at 7:04 PM

$NMRA There u go another overnight swing winner🚨🚨

0 · Reply

EC100 Oct. 24 at 6:53 PM

$NMRA holding over weekend, interesting Monday

0 · Reply

Kaltycoon Oct. 24 at 6:21 PM

$NMRA someone gambling millions of dollar on this, just saying. At this point could go either way. Black or Red for Monday spin.

1 · Reply

_www_larval_com_ Oct. 24 at 3:17 PM

$NMRA has shot 5% higher to 7% (~2Mv) in the last few minutes, 11/21 options, follow for more volatility.

0 · Reply

Mr_GA Oct. 24 at 2:42 PM

0 · Reply

Kaltycoon Oct. 24 at 2:29 PM

$NMRA $NMRA nice staircase build on this, some big cahoonas scooping the dips - I’m intrigued even more.

0 · Reply

Mr_GA Oct. 24 at 2:25 PM

$NMRA MULTIPLE candidates in NMRA's pipeline. Maybe some interest from big pharma eventually? Former affiliations with Amgen and Biogen. https://neumoratx.com/pipeline/

0 · Reply

Mr_GA Oct. 24 at 2:12 PM

$NMRA Holding $2 so far. Came up off the $2.08 dip. Long term winner, IMO. Multiple (7) candidates in their pipeline.

0 · Reply

OliverBroderick Oct. 24 at 1:59 PM

$NMRA increased position massively on dip. In this for long run

0 · Reply

LongTermInvestingCKramer Oct. 24 at 1:47 PM

$NMRA just added more. it now has my blessing to go higher

0 · Reply

Kaltycoon Oct. 24 at 1:05 PM

$NMRA why is presentation delayed?

1 · Reply

PLATINUM_TRADES Oct. 24 at 12:11 PM

$NMRA Moving up.. $2.55 Has to break next🚨🚨

0 · Reply

Mr_GA Oct. 24 at 11:54 AM

$NMRA

0 · Reply

EvCe Oct. 24 at 10:41 AM

$NMRA that gap at $12… would be a shame to leave it like that 😎

0 · Reply

Thess5 Oct. 24 at 9:25 AM

$TOVX ⬆️⬆️⬆️.50+ by 9:30am. Our premarket Gapper! $NMRA 🔍 $VTYX 🔍 $PRPL 🔍 $AVNT 🔍

0 · Reply

PLATINUM_TRADES Oct. 24 at 4:26 AM

$NMRA Love the break here $2.55 to break next🥩🥩🥩🥩

0 · Reply

Mr_GA Oct. 24 at 12:49 AM

$NMRA Sign up at the link below for Neumora Therapeutics Virtual R&D Day on October 27, 2025 at 8 am ET. https://edge.media-server.com/mmc/p/bz7ccx5q/

0 · Reply

FreshlySqueezed23 Oct. 24 at 12:31 AM

$NMRA joined the party holding 2K at 2.23

0 · Reply

Market Cap	374.09M
Revenue (ttm)	0.00
Net Income (ttm)	-243.79M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.11

Volume	5,447,800
Avg Vol	945,008
Day's Range	N/A - N/A
Shares Out	161.95M
Stochastic %K	91%
Beta	2.92
Analysts	Sell
Price Target	$7.00